Purpose@#To
report a case of late opacification of a hydrophilic acrylic monofocal
intraocular lens (IOL) with a hydrophobic surface (CT SPHERIS® 204) after a second
vitrectomy in a
patient with proliferative
diabetic retinopathy.Case
summary:
A 50-year-old
male with diabetes presented with decreased
visual acuity in the right
eye. He had undergone
phacoemulsification and IOL (CT SPHERIS® 204) implantation,
vitrectomy, endolaser
photocoagulation, and intravitreal
bevacizumab (
Avastin®)
injection due to
vitreous hemorrhage in the right
eye about 43 months prior. Four months after the
surgery, presenting with recurrent
vitreous hemorrhage and neovascularization of the angle, he underwent partial
vitrectomy and intravitreal and intracameral
bevacizumab (
Avastin®)
injection. The best-corrected
visual acuity was 0.1 in the right
eye when he presented with decreased
visual acuity.
Slit lamp examination of the right
eye showed diffuse whitish granular opacity on the surface of the IOL. The IOL was explanted, together with the capsular bag, and examined using
scanning electron microscopy and energy-dispersive
X-ray spectroscopy. @*Conclusions@#This case is the first to
report late opacification of a hydrophilic, acrylic monofocal IOL with a hydrophobic surface, the CT SPHERIS® 204. It is necessary to be cautious in using this type of lens in
patients with
diabetic retinopathy.